Código QR (código de barras bidimensional)

Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study

ABSTRACT Background Although neoadjuvant chemoimmunotherapy has emerged as a promising approach for resectable non‐small cell lung cancer (NSCLC), comparative real‐world data on different PD‐1 inhibitors are limited. This study compared the clinical efficacy, pathological response, survival, and saf...

ver descrição completa

Na minha lista:
Principais autores: Bo Yan, Xiaoxuan Sun, Yan Sheng, Ran Zhang, Yanjun Su, Yulong Chen
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2025-07-01
coleção:Thoracic Cancer
Assuntos:
chemoimmunotherapy
immune checkpoint inhibitors
neoadjuvant therapy
non‐small cell lung cancer
surgery
Acesso em linha:https://doi.org/10.1111/1759-7714.70123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados